(Q48474064)

11 February 2018

editorial

0 references

title

Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease. (English)

1 reference

11 February 2018

0 references

0 references

M Verri

1

1 reference

11 February 2018

O Pastoris

2

1 reference

11 February 2018

M Dossena

3

1 reference

11 February 2018

R Aquilani

4

1 reference

11 February 2018

F Guerriero

5

1 reference

11 February 2018

G Cuzzoni

6

1 reference

11 February 2018

L Venturini

7

1 reference

11 February 2018

G Ricevuti

8

1 reference

11 February 2018

A I Bongiorno

9

1 reference

11 February 2018

publication date

1 April 2012

1 reference

11 February 2018

International Journal of Immunopathology and Pharmacology

published in

1 reference

11 February 2018

volume

25

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

345-353

1 reference

11 February 2018

Alzheimer's disease: effects of β-amyloid on mitochondria

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

The amyloid precursor protein: beyond amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Alzheimer' s disease, oxidative stress and gammahydroxybutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Mitoenergetic failure in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Effect of amyloid beta-peptide on permeability transition pore: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Energy metabolism inhibition impairs amyloid precursor protein secretion from Alzheimer's fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Gender differences in glutathione metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Neuroinflammatory processes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

Amyloid precursor protein and amyloid β-peptide bind to ATP synthase and regulate its activity at the surface of neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201202500204

10.1177/039463201202500204

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

22697066

1 reference

11 February 2018